| |
| |
|
| Insider
Information: |
Mueller Brian |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
82,159 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,395,452 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
82,159 |
|
|
| Total
Value |
$6,395,452 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Financial O... |
2024-05-30 |
72,159 |
|
0 |
Premium* |
|
|
Anthera Pharmaceuticals Inc |
ANTH |
|
2015-12-23 |
10,000 |
2015-12-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
139 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2014-12-02 |
4 |
OE |
$28.23 |
$141,150 |
D/D |
5,000 |
9,593 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2024-05-30 |
4 |
AS |
$75.19 |
$375,950 |
D/D |
(5,000) |
72,159 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2024-05-30 |
4 |
OE |
$63.10 |
$315,500 |
D/D |
5,000 |
77,159 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-03-01 |
4 |
S |
$59.74 |
$300,067 |
D/D |
(5,023) |
15,294 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-03-01 |
4 |
OE |
$14.39 |
$91,464 |
D/D |
5,023 |
20,317 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-11-23 |
4 |
AS |
$95.09 |
$531,092 |
D/D |
(5,379) |
28,847 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2021-04-01 |
4 |
AS |
$76.30 |
$434,300 |
D/D |
(5,692) |
31,016 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,710 |
17,973 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,780 |
17,028 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Acting CFO |
• – – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,800 |
19,768 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-12-02 |
4 |
OE |
$67.81 |
$400,079 |
D/D |
5,900 |
31,507 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2021-05-07 |
4 |
AS |
$79.50 |
$533,366 |
D/D |
(6,709) |
31,357 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2021-05-07 |
4 |
OE |
$28.23 |
$189,395 |
D/D |
6,709 |
38,066 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Acting CFO |
• – – |
2020-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,730 |
25,195 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2014-12-01 |
4 |
OE |
$14.39 |
$145,785 |
D/D |
6,950 |
11,543 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2014-12-01 |
4 |
S |
$90.25 |
$627,238 |
D/D |
(6,950) |
4,593 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2015-03-03 |
4 |
S |
$109.46 |
$766,210 |
D/D |
(7,000) |
8,800 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2015-03-03 |
4 |
OE |
$28.23 |
$197,610 |
D/D |
7,000 |
15,800 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-12-02 |
4 |
AS |
$104.50 |
$731,605 |
D/D |
(7,001) |
27,746 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-07-08 |
4 |
AS |
$89.50 |
$656,662 |
D/D |
(7,337) |
30,726 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2017-05-08 |
4 |
AS |
$91.17 |
$687,334 |
D/D |
(7,482) |
13,468 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-05-03 |
4 |
S |
$67.11 |
$503,295 |
D/D |
(7,500) |
9,403 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-05-03 |
4 |
OE |
$21.51 |
$161,325 |
D/D |
7,500 |
16,903 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-11-05 |
4 |
OE |
$14.39 |
$115,120 |
D/D |
8,000 |
23,340 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-11-05 |
4 |
AS |
$46.00 |
$376,250 |
D/D |
(8,000) |
15,340 |
0 |
- |
|
139 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
